<DOC>
	<DOCNO>NCT01113658</DOCNO>
	<brief_summary>The purpose study assess efficacy design improvement Spiracur SNaP Wound Care System . This study prospectively evaluate safety efficacy current new design iteration component FDA-cleared Spiracur SNaP Wound Care System order optimize safety , efficacy , system performance .</brief_summary>
	<brief_title>Clinical Evaluation SNaP Wound Care System</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<mesh_term>Postphlebitic Syndrome</mesh_term>
	<mesh_term>Postthrombotic Syndrome</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Wound &lt; 10 cm great diameter Patient &gt; 18 year age Willing able sign inform consent Patients woundrelated cellulitis Patients thick eschar wound base post debridement Patients wound located area amenable form air tight seal Ulcers due inflammatory condition pyodermagangrenosum , rheumatoid arthritis , vasculitis , cryoglobulinemia , necrobiosislipoidicadiabeticorum , lupus pancreatic panniculitis , cryofibrinogenemia , calcinosis cutis , scleroderma , Raynaud 's syndrome Patient untreated osteomyelitis Patient allergic wound care product Patient wound expose blood vessel suitable negative pressure therapy Pregnant pregnancysuspected patient Subject actively participate clinical trial conflict current study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>negative pressure wound therapy</keyword>
	<keyword>NPWT</keyword>
	<keyword>Spiracur</keyword>
	<keyword>SNaP Wound Care System</keyword>
</DOC>